Annotation Detail

Information
Associated Genes
MET
Associated Variants
MET MUTATION
MET MUTATION
Associated Disease
Malignant neoplasm of prostate
Source Database
DisGeNET
Description
These findings establish the importance of MET in prostate cancer progression but reveal potential limitations in the clinical use of MET inhibitors in late-stage prostate cancer.
Pubmed
25381262
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
8
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00352874433704394
Drugs